X-123186065-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_007325.5(GRIA3):c.268+75T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.393 in 844,117 control chromosomes in the GnomAD database, including 45,981 homozygotes. There are 99,862 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 5101 hom., 11181 hem., cov: 22)
Exomes 𝑓: 0.40 ( 40880 hom. 88681 hem. )
Consequence
GRIA3
NM_007325.5 intron
NM_007325.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.119
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant X-123186065-T-C is Benign according to our data. Variant chrX-123186065-T-C is described in ClinVar as [Benign]. Clinvar id is 1259476.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.631 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIA3 | NM_000828.5 | c.268+75T>C | intron_variant | ENST00000622768.5 | NP_000819.4 | |||
GRIA3 | NM_007325.5 | c.268+75T>C | intron_variant | ENST00000620443.2 | NP_015564.5 | |||
GRIA3 | NM_001256743.2 | c.268+75T>C | intron_variant | NP_001243672.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIA3 | ENST00000620443.2 | c.268+75T>C | intron_variant | 1 | NM_007325.5 | ENSP00000478489.1 | ||||
GRIA3 | ENST00000622768.5 | c.268+75T>C | intron_variant | 5 | NM_000828.5 | ENSP00000481554.1 |
Frequencies
GnomAD3 genomes AF: 0.350 AC: 38627AN: 110423Hom.: 5105 Cov.: 22 AF XY: 0.342 AC XY: 11176AN XY: 32719
GnomAD3 genomes
AF:
AC:
38627
AN:
110423
Hom.:
Cov.:
22
AF XY:
AC XY:
11176
AN XY:
32719
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.399 AC: 292811AN: 733637Hom.: 40880 AF XY: 0.433 AC XY: 88681AN XY: 204883
GnomAD4 exome
AF:
AC:
292811
AN:
733637
Hom.:
AF XY:
AC XY:
88681
AN XY:
204883
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.350 AC: 38617AN: 110480Hom.: 5101 Cov.: 22 AF XY: 0.341 AC XY: 11181AN XY: 32786
GnomAD4 genome
AF:
AC:
38617
AN:
110480
Hom.:
Cov.:
22
AF XY:
AC XY:
11181
AN XY:
32786
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at